Modulating vascular smooth muscle cell phenotype via Wnt-Independent FRZB pathways.

Area of Science:

• Vascular Biology
• Atherosclerosis Pathogenesis
• Cell Phenotype Modulation

Background:

• Vascular smooth muscle cells (VSMCs) are key in atherosclerosis, shifting from contractile to synthetic phenotypes.
• FRZB, a Wnt signaling modulator, is linked to vascular disease, but its role in VSMC phenotype is unclear.

Purpose of the Study:

• To investigate the role of FRZB in regulating VSMC phenotype.
• To determine FRZB's impact on VSMC migration, proliferation, and marker expression.

Main Methods:

• Categorized VSMC regions by FRZB expression.
• Performed differential gene expression, KEGG, and Disease Ontology analyses.
• Utilized siRNA for FRZB knockdown in human aortic VSMCs and assessed cell behavior.

Main Results:

• FRZB expression was lower in synthetic VSMCs compared to contractile VSMCs.
• FRZB knockdown increased VSMC migration and proliferation, decreasing contractile markers while increasing synthetic markers.
• FRZB knockdown unexpectedly suppressed Wnt signaling, implicating PI3K-Akt and ECM pathways.

Conclusions:

• Reduced FRZB expression correlates with a synthetic VSMC phenotype and atherosclerosis markers.
• FRZB may regulate VSMC behavior via non-Wnt pathways, suggesting it as a therapeutic target.
• Stabilizing VSMCs by targeting FRZB could be a strategy for atherosclerosis management.